Zobrazeno 1 - 10
of 48
pro vyhledávání: '"James E. Patrick"'
Autor:
James E. Patrick, Joshua K. Radi
Publikováno v:
Physician Assistant Clinics. 4:739-749
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f68ffbea64d582002bfc6a49271b20bf
https://doi.org/10.1016/j.cpha.2019.06.004
https://doi.org/10.1016/j.cpha.2019.06.004
Autor:
James E Patrick
Publikováno v:
Characters and Characterization In The Book of Samuel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5be961d88f3b73092b1c2f8cd52bbee
https://doi.org/10.5040/9780567680884.ch-017
https://doi.org/10.5040/9780567680884.ch-017
Autor:
James E. Patrick
Publikováno v:
The Journal of Theological Studies. 61:43-81
Outlines of Matthew's Gospel tend to focus either on a distinction between discourse and narrative (Bacon's 'five books', or subsequent chiastic proposals), or on a narrative plot outline, often attributed to Mark's Gospel. Both have significant weak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6caf1af2e94a3fd727d594b5b88a071
https://doi.org/10.1093/jts/flq012
https://doi.org/10.1093/jts/flq012
Publikováno v:
International Journal of Peptide and Protein Research. 14:479-484
Thymopoietin32--36 (TP5) is a synthetic pentapeptide that has the biological activity of its parent molecule, the 49 amino acid thymic hormone thymopoietin. Tritiated thymopoietin32--36 (3 /-TP5) was prepared by reductive tritiation of dibromotyrosyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc2c8c29456b6796ac2e2952660470f
https://doi.org/10.1111/j.1399-3011.1979.tb01959.x
https://doi.org/10.1111/j.1399-3011.1979.tb01959.x
Autor:
Larisa Reyderman, N. Alvarez, A.-D. Su, Swapan K. Chowdhury, Kevin B. Alton, Mark A. Wirth, James E. Patrick, Robert P. Clement, Ragulan Ramanathan, Paul Statkevich
Publikováno v:
Xenobiotica. 37:770-787
The absorption, metabolism and excretion of desloratadine (DL, Clarinex) were characterized in six healthy male volunteers. Subjects received a single oral 10-mg dose of [(14)C]DL ( approximately 104 microCi). Blood, urine and feces were collected ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::970826460900afc03da4b5ebc043bf30
https://doi.org/10.1080/00498250701463325
https://doi.org/10.1080/00498250701463325
Autor:
A.-D. Su, Robert P. Clement, K.M. Kulmatycki, Larisa Reyderman, James E. Patrick, N. Alvarez, Kevin B. Alton, Mark A. Wirth, Swapan K. Chowdhury, Paul Statkevich, Ragulan Ramanathan
Publikováno v:
Xenobiotica. 37:753-769
The absorption, metabolism and excretion of carbon-14-labeled loratadine (LOR, SCH 29851, Claritin) administered orally to healthy male volunteers were evaluated. Following a single oral 10-mg dose of [(14)C]LOR ( approximately 102 microCi), concentr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de0029e5711c789e1f8f8fd5981d0f4
https://doi.org/10.1080/00498250701463317
https://doi.org/10.1080/00498250701463317
Autor:
Ragulan Ramanathan, A.-D. Su, Swapan K. Chowdhury, James E. Patrick, N. Alvarez, Kevin B. Alton, K Stauber
Publikováno v:
Xenobiotica. 35:155-189
The metabolism and excretion of loratadine (LOR), a long-acting non-sedating antihistamine, have been evaluated in male and female mice, rats and monkeys. Following a single (8 mg kg-1) oral administration of [14C]LOR, radioactivity was predominantly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864cbba0b9b872220737381f967175e3
https://doi.org/10.1080/00498250500038906
https://doi.org/10.1080/00498250500038906
Autor:
Swapan K. Chowdhury, Robert M. Iannucci, Kevin B. Alton, Neil Hapangama, Anima Ghosal, Yuan Yuan, James E. Patrick, Shmuel Zbaida, Joana Achanfuo-Yeboah
Publikováno v:
Drug Metabolism and Disposition. 32:314-320
Ezetimibe [1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone] (Zetia; Schering-Plough, Kenilworth, NJ) is the first in a new class of cholesterol-lowering agents known as cholesterol absorption inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a3f1555d40c814c045d0d01e1e2cbd
https://doi.org/10.1124/dmd.32.3.314
https://doi.org/10.1124/dmd.32.3.314
Autor:
Vijay Batra, James E. Patrick, Bo Yang, L. Mellars, Melton B. Affrime, Enrico P. Veltri, Teddy Kosoglou, Yali Zhu, David L. Cutler, Stephen E. Maxwell, Paul Statkevich, Ingo Meyer
Publikováno v:
British Journal of Clinical Pharmacology. 54:309-319
Aims The primary aims of these two single-centre, randomized, evaluator-blind, placebo/positive-controlled, parallel-group studies were to evaluate the potential for pharmacodynamic and pharmacokinetic interaction between ezetimibe 0.25, 1, or 10 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f9460a8093805cd2bbf3c21aa4338b5
https://doi.org/10.1046/j.1365-2125.2002.01633.x
https://doi.org/10.1046/j.1365-2125.2002.01633.x
Autor:
James E. Patrick, Christopher Horvath, Richard E. Morrissey, Eileen A. Snyder, James S. MacDonald
Publikováno v:
Toxicological Sciences. 65:266-275
SCH 58500 is a replication-defective recombinant adenoviral vector containing the cloned human wild-type (normal) tumor suppressor gene p53. SCH 58500 is in trials to evaluate potential clinical utility. A series of toxicology studies in rats and mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2776e1ef299c13a5264ea73834bac07d
https://doi.org/10.1093/toxsci/65.2.266
https://doi.org/10.1093/toxsci/65.2.266